Sally T. Ishizaka

The Extra Domain A of Fibronectin Activates Toll-like Receptor 4

Yoshinori Okamura, Michiko Watari, Elliot S. Jerud et al. · Journal of Biological Chemistry · 2001 · 1.2K citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Novel Small Molecule Inhibitors of TLR7 and TLR9: Mechanism of Action and Efficacy In Vivo

Marc S. Lamphier, Wanjun Zheng, Eicke Latz et al. · Molecular Pharmacology · 2013 · 141 citations

Life Sciences, Immunology, Pharmacology +17

Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria

Bernardo S. Franklin, Sally T. Ishizaka, Marc S. Lamphier et al. · Proceedings of the National Academy of Sciences · 2011 · 126 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Novel Class of Endotoxin Receptor Agonists with Simplified Structure, Toll-Like Receptor 4-Dependent Immunostimulatory Action, and Adjuvant Activity

Lynn D. Hawkins, Sally T. Ishizaka, Pamela D. McGuinness et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 62 citations

Life Sciences, Immunology, Pharmacology +15

Synthetic Toll-Like Receptor 4 Agonist Enhances Vaccine Efficacy in an Experimental Model of Toxic Shock Syndrome

Garry L. Morefield, Lynn D. Hawkins, Sally T. Ishizaka et al. · Clinical and Vaccine Immunology · 2007 · 57 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17